Zetia Buyers Defend Class Cert. As 'Common Business Sense'

By Bryan Koenig · February 9, 2022, 5:33 PM EST

Direct buyers of cholesterol drug Zetia urged a Virginia federal court Tuesday to reject a recommendation against class certification in multidistrict litigation accusing Merck and Glenmark of scheming to delay generic...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login